New study aims to make food allergy treatment safer and more tolerable
NCT ID NCT06256146
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests modified oral immunotherapy (OIT) protocols for peanut, milk, and egg allergies in 360 participants. The goal is to see if using lower doses or processed allergens can reduce allergic reactions during treatment while still helping people become desensitized to their allergen. The study compares different OIT approaches to find a safer, more tolerable option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EGG ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Institute of the McGill University Health Centre
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peanut allergy cure in sight? trial tests tolerance in teens
- Could a Mother's diet during pregnancy prevent peanut and egg allergies in her baby?
- Can a shot tame peanut allergies? small study tests xolair
- Can allergy drugs help kids tolerate peanut and more?
- Peanut allergy patch enters human safety trials
- Could supermarket peanuts and milk cure food allergies? new study investigates.